Overview

A Study to Prevent Infantile Spasms Relapse

Status:
RECRUITING
Trial end date:
2028-06-30
Target enrollment:
Participant gender:
Summary
After initially successful treatment, many children with infantile spasms unfortunately have a relapse, and relapse is linked to poor long-term outcomes such as autism and other forms of epilepsy. The aim of this study is to determine if treatment with low-dose prednisolone is safe, well tolerated, and effective in reducing the risk of relapse.
Phase:
PHASE2
Details
Lead Sponsor:
University of California, Los Angeles
Collaborator:
Pediatric Epilepsy Research Foundation
Treatments:
Famotidine
Prednisolone